OncoSec Medical (FRA:ONMA) Net Change in Cash : €-20.94 Mil (TTM As of Jan. 2023)

View and export this data going back to 2015. Start your Free Trial

What is OncoSec Medical Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

OncoSec Medical's Net Change in Cash for the three months ended in Jan. 2023 was €-1.89 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jan. 2023 was €-20.94 Mil.

OncoSec Medical Net Change in Cash Historical Data

The historical data trend for OncoSec Medical's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoSec Medical Net Change in Cash Chart

OncoSec Medical Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Net Change in Cash

Get a 7-Day Free Trial

-6.54

19.04

-4.17

21.65

-33.08

OncoSec Medical Quarterly Data
	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23
Net Change in Cash	Get a 7-Day Free Trial															-9.04	-5.33	-7.06	-6.67	-1.89

OncoSec Medical Net Change in Cash Calculation

OncoSec Medical's Net Change in Cash for the fiscal year that ended in Jul. 2022 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-31.592	+	-0.241	+	-1.142	+	-0.105
	=	-33.08

OncoSec Medical's Net Change in Cash for the quarter that ended in Jan. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -6.135 + 0 + 4.175 + 0.071

= -1.89

Net Change in Cash for the trailing twelve months (TTM) ended in Jan. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-20.94 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoSec Medical Net Change in Cash Related Terms
Thank you for viewing the detailed overview of OncoSec Medical's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoSec Medical (FRA:ONMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoSec Medical Inc (FRA:ONMA) » Definitions » Net Change in Cash

Comparable Companies

NOVNQ USRM OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE SZSE:300122 ALNY OCSE:GMAB XKRX:068270 BMRN XBRU:UCB RPRX

Traded in Other Exchanges

ONCSQ:USA

Address

24 North Main Street, Pennington, NJ, USA, 08534

Website

https://www.oncosec.com

OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.

OncoSec Medical (FRA:ONMA) Headlines

No Headlines